Quest AD-Detect® Phosphorylated tau217(p-tau217), Plasma
Test Code
Clinical Significance
Quest AD-Detect® Phosphorylated tau217(p-tau217), Plasma - Current research indicates that plasma p-tau, including p-tau 217, is concordant with amyloid status defined by either CSF biomarker testing or PET scan analysis, and is able to differentiate between AD and non-AD neurodegenerative diseases and to predict progression to AD. Blood-based biomarkers, such as plasma p-tau, could potentially be used as inclusion criteria or to evaluate target engagement and treatment efficacy, and could further advance the development of disease-modifying treatments in the field of AD and related disorders. This assay is designed specifically for the quantitative measurement of tau phosphorylated at threonine 217 (p-tau 217) in human plasma.
Test Resources
Test Details
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
0.7 mL plasma collected in an EDTA (lavender-top) tube
Minimum Volume
0.5 mL
Collection Instructions
Follow standard protocol for specimen collection and centrifugation then transfer plasma to a labeled plastic transport tube.
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 5 days
Refrigerated: 14 days
Frozen: 28 days
Setup Schedule
Refrigerated: 14 days
Frozen: 28 days